Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer

Carcinogenesis

Volumn 26, Issue 7, 2005, Pages 1263-1271

  Broberg, Karin ^a   Björk, Jonas ^b   Paulsson, Karin ^a   Höglund, Mattias ^a   Albin, Maria ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; ASPARAGINE; CARCINOGEN; EPOXIDE HYDROLASE; GENOMIC DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; NUCLEASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); GLUTATHIONE S-TRANSFERASE M1;

ALKYLATION; ARTICLE; BIOTRANSFORMATION; BLADDER CANCER; CANCER RISK; CHEEK; CHROMOSOME SIZE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; GENOTYPE; HEREDITY; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METABOLISM; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TELOMERE; ULTRAVIOLET RADIATION; ADULT; AGED; BLADDER TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; SMOKING; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENS; CASE-CONTROL STUDIES; DNA DAMAGE; DNA REPAIR; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; RISK FACTORS; SMOKING; TELOMERE; URINARY BLADDER NEOPLASMS;

EID: 22844444113     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi063     Document Type: Article

References (45)

1. Blackburn,E.H. (2001) Switching and signaling at the telomere. Cell 106, 661-673.
2. McClintock,B. (1941) The stability of broken ends of chromosomes in Zea mays. Genetics, 26, 234-282.
3. McClintock,B. (1942) The fusion of broken ends of chromosomes following nuclear fusion. Proc. Natl Acad. Sci. USA, 28, 458-463.
4. Hande,M.P., Samper,E., Lansdorp,P. and Blasco,M.A. (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol., 144, 589-601.
5. Harley,C.B., Futcher,A.B. and Greider,C.W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458-460.
6. Watson,J.D. (1972) Origin of concatemeric DNA. Nat. New Biol., 239, 197-201.
7. Olovnikov,A.M. (1973) A theory of marginotomy: The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the problem. J. Theor. Biol., 41, 181-190.
8. Mathon,N.F. and Lloyd,A.C. (2001) Cell senescence and cancer. Nat. Rev. Cancer, 1, 203-213.
9. Rudolph,K.L., Chang,S., Lee,H.W., Blasco,M., Gottlieb,G.J., Greider,C. and DePinho,R.A. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96, 701-712.
10. Artandi,S.E., Chang,S., Lee,S.L., Alson,S., Gottlieb,G.J., Chin,L. and DePinho,R.A. (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature, 406, 641-645.
11. von Zglinicki,T. (2002) Oxidative stress shortens telomeres. Trends Biochem. Sci., 27, 339-344.
12. Petersen,S., Saretzki,G. and von Zglinicki,T. (1998) Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp. Cell Res., 239, 152-160.
13. Iwama,H., Ohyashiki,K., Ohyashiki,J.H. et al. (1998) Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum. Genet., 102, 397-402.
14. Rufer,N., Brummendorf,T.H., Kolvraa,S., Bischoff,C., Christensen,K., Wadsworth,L., Schulzer,M. and Lansdorp,P.M.(1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med., 190, 157-167.
15. World Health Organization (1973) Histological Typing of Urinary Bladder Tumors: International Histological Classification of Tumors. Geneva.
16. Hermanek,P. and Sobin,L.H. (1987) UICC - International Union Against Cancer TNM Classification of Malignant Tumors. Springer Verlag, Heidelberg.
17. Badawi,A.F., Hirvonen,A., Bell,D.A., Lang,N.P. and Kadlubar,F.F. (1995) Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55, 5230-5237.
18. Taylor,J.A., Umbach,D.M., Stephens,E., Castranio,T., Paulson,D., Robertson,C., Mohler,J.L. and Bell,D.A. (1998) The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction. Cancer Res., 58, 3603-3610.
19. Hung,R.J., Boffetta,P., Brennan,P. et al. (2002) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer, 110, 598-604.
20. Benhamou,S., Reinikainen,M., Bouchardy,C., Dayer,P. and Hirvonen,A. (1998) Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res., 58, 5291-5293.
21. Hou,S.-M., Lambert,B. and Hemminki,K. (1995) Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSM1 and NAT2 in bus maintenance workers. Carcinogenesis, 16, 1913-1917.
22. Pemble,S., Schroeder,K.R., Spencer,S.R., Meyer,D.J., Hallier,E., Bolt,H.M., Ketterer,B. and Taylor,J.B. (1994) Human glutathione S-transferase theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 300, 271-276.
23. Storm,N., Darnhofer-Patel,B., van den Boom,D. and Rodi,C.P. (2003) MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol. Biol. 212, 241-262.
24. Cawthon,R.M. (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res., 30, e47.
25. Wu,X., Amos,C.I., Zhu,Y., Zhao,H., Grossman,B.H., Shay,J.W., Luo,S., Hong,W.K. and Spitz,M.R. (2003) Telomere dysfunction: A potential cancer predisposition factor. J. Natl Cancer Inst., 95, 1211-1218.
26. Greenland,S. and Rothman,K.J. (1998) Modern Epidemiology, 2nd edn. Lippincott Raven, Philadelphia, pp. 329-342.
27. Meeker,A.K., Hicks,J.L., Iacobuzio-Donahue,C.A., Montgomery,E.A., Westra,W.H., Chan,T.Y., Ronnett,B.M. and De Marzo,A.M. (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res., 10, 3317-3326.
28. Cottliar,A., Pedrazzini,E., Corrado,C., Engelberger,M.I., Narbaitz,M. and Slavutsky,I. (2003) Telomere shortening in patients with plasma cell disorders. Eur. J. Haematol., 7, 334-340.
29. Engel,L.S., Taioli,E., Pfeiffer,R. et al. (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review. Am. J. Epidemiol., 156, 95-109.
30. Hu,Z., Wei,Q., Wang,X. and Shen,H. (2004) DNA repair gene XPD polymorphism and lung cancer risk: A meta-analysis. Lung Cancer, 46, 1-10.
31. Rybicki,B.A., Conti,D.V., Moreira,A., Cicek,M., Casey,G. and Witte,J.S. (2004) DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., 13, 23-29.
32. Hou,S.M., Fält,S., Angelini,S., Yang,K., Nyberg,F., Lambert,B. and Hemminki,K. (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis, 23, 599-603.
33. Tang,D., Cho,S., Rundle,A., Chen,S., Phillips,D., Zhou, J., Hsu,Y., Schnabel,F., Estabrook,A. and Perera,F.P. (2002) Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res. Treat., 75, 159-166.
34. Zhou,W., Liu,G., Miller,D.P., Thurston,S.W., Xu,L.L., Wain,J.C., Lynch,T.J., Su, L. and Christiani,D.C. (2002) Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res., 62, 1377-1381.
35. Moncollin,V., Vichim,P. and Egly,J.-M. (2001) A transcription factor involved in DNA repair and cell-cycle regulation. In Nlckoloff,J.A. and Hoekstra,M.F. (eds), DNA Damage and Repair. Humana Press Inc., Totowa, Vol. 2, pp.143-159.
36. Qiao,Y., Spitz,M.R., Shen,H., Guo,Z., Shete,S., Hedayati,M., Grossman,L., Mohrenweiser,H. and Wei,Q. (2002) Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis, 23, 295-299.
37. Spitz,M.R., Wu,X., Wang,Y., Wang,L.E., Shete,S., Amos,C.I., Guo,Z., Lei,L., Mohrenweiser,H. and Wei,Q. (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res., 61, 1354-1357.
38. Blankenburg,S., Konig,I.R., Moessner,R. et al. (2005) No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur. J. Hum. Genet., 13, 253-255.
39. Sanyal,S., Festa,F., Sakanom,S., Zhang,Z., Steineckm,G., Norming,U., Wijkström,H., Larsson,P., Kumar,R. and Hemminki,K. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis, 25, 729-734.
40. Marcus,P.M., Hayes,R.B., Vineis,P. et al. (2000) Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol. Biomarkers Prev., 9, 461-467.
41. Marcus,P.M., Vineis,P. and Rothman,N. (2000) NAT2 slow acetylation and bladder cancer risk: A meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics, 10, 115-122.
42. Frenck,W.Jr, Blackburn,E.H. and Shannon,K.M. (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl Acad. Sci. USA, 95, 5607-5610.
43. Boström,G., Hallqvist,J., Haglund,B.J., Romelsjö,A., Svanström,L. and Diderichsen,F. (1993) Socioeconomic differences in smoking in an urban Swedish population. The bias introduced by non-participation in a mailed questionnaire. Scand. J. Soc. Med., 21, 77-82.
44. Slagboom,P.E., Droog,S. and Boomsma,D.I. (1994) Genetic determination of telomere size in humans: A twin study of three age groups. Am. J. Hum. Genet., 55, 876-882.
45. von Zglinicki,T., Serra,V., Lorenz,M., Saretzki,G., Lenzen-Grossimlighaus,R., Gessner,R., Risch,A. and Steinhagen-Thiessen,E. (2000) Short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor? Lab. Invest., 80, 1739-1747.